High-performance liquid chromatographic stability indicating assay method of tianeptine sodium with simultaneous fluorescence and UV detection

Journal of Chromatographic Science

Volumn 45, Issue 6, 2007, Pages 305-310

  Khedr, Alaa ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34347381070     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/45.6.305     Document Type: Article

References (10)

1. R. Defrance, C. Marey, and A. Kamoun. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clin. Neuropharmacol. 11(suppl 2): S74-82 (1988).
2. G. Nicot, G. Lachatre, C. Gonnet, J. Mallon, and E. Mocaer. Ion-pair extraction and high-performance liquid chromatographic determination of tianeptine and its metabolites in human plasma, urine and tissues. J. Chromatogr. 381: 115-26 (1986).
3. J.M. Gaulier, P. Marquet, E. Lacassie, R. Desroches, and G. Lachatre. High-performance liquid chromatographic determination of tianeptine in plasma applied to pharmacokinetic studies. J. Chromatogr. B Biomed. Appl. 748: 407-14 (2000).
4. U.S. Tatar. Determination of tianeptine in human plasma using high-performance liquid chromatography with fluoroscence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 834: 62-7 (2006).
5. M.B. Nair, J.J. Aaron, P. Prognon, and G. Mahuzier. Photochemically induced fluorimetric detection of tianeptine and some of its metabolites. Application to pharmaceutical preparation. Analyst. 123: 2267-70 (1998).
6. E. Novakova. Detection of new antidepressive agents using thin-layer chromatography. Soud Lek. 49: 2-6 (2004).
7. The Firm of Hueschen and Sage, US Patent 0037021 Al (2001). 8. Impurities in new drug substances. Fed. Regist. 61(3): January 4, 1996, p. 372.
8. Acceptance criteria for new drug substances, and new drug products, chemical substances. Fed. Regist. 62(227): p. 62890 (1997).
9. ICH topic QI A. "Stability testing of new active substances and medicinal products". ICH Harmonized Tripartite Guidelines. ICH, Geneva, Switzerland, November 5, 1996, CPMP/ICH/280/95.
10. ICH topic Q2B. "Validation of analytical procedures: methodology". ICH Harmonized Tripartite Guidelines. ICH, Geneva, Switzerland, November 6, 1996, CPMP/ICH/281/95.